Highlights and Quick Summary
- Share Based Compensation of Revenue for the quarter ending December 31, 2022 was -8.93% (a -170.26% decrease compared to previous quarter)
- Year-over-year quarterly Share Based Compensation of Revenue decreased by -169.12%
- Annual Share Based Compensation of Revenue for 2022 was 40.07% (a -60.52% decrease from previous year)
- Annual Share Based Compensation of Revenue for 2021 was 101.5% (a 67.63% increase from previous year)
- Annual Share Based Compensation of Revenue for 2020 was 60.55% (a 86.88% increase from previous year)
- Twelve month Share Based Compensation of Revenue ending December 31, 2022 was 40.07% (a 24.63% increase compared to previous quarter)
- Twelve month trailing Share Based Compensation of Revenue decreased by -30.89% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| 40.07% | 32.15% | 54.52% | 57.98% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Share Based Compensation of Revenue of Precigen, Inc.
Most recent Share Based Compensation of Revenueof PGEN including historical data for past 10 years.Interactive Chart of Share Based Compensation of Revenue of Precigen, Inc.
Precigen, Inc. Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -8.93% | 12.71% | 79.32% | 12.92% | 40.07% |
| 2021 | -14.04% | 74.71% | 93.24% | 24.45% | 101.5% |
| 2020 | -8.67% | 19.83% | 16.1% | 17.77% | 60.55% |
| 2019 | 40.41% | 42.2% | 14.98% | 43.77% | 32.4% |
| 2018 | 30.33% | 34.05% | 25.16% | 36.06% | 31.08% |
| 2017 | 18.85% | 32.13% | 27.18% | 20.11% | 24.01% |
| 2016 | 30.57% | 27.33% | 17.63% | 37.46% | 27.75% |
| 2015 | 33.33% | 15.71% | 17.55% | 31.73% | 23.52% |
| 2014 | 22.44% | 20.05% | 58.61% | 53.48% | 31.05% |
| 2013 | 15.46% | 10.92% | 13.36% | 9.96% | 12.82% |
| 2012 | 15.32% | 21.86% | – | – | 11.26% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology